Paths to Progress: Understanding Policy’s Broad Impact on US Leadership in Biopharma

We Work For Health recently convened a conversation to explore the impact policy decisions have on the biopharmaceutical industry and opportunities to help inform the Congressional Budget Office as it reviews future legislation. Watch the full discussion here: